- Home
- TRV vs HLN Comparison
TRV vs HLN Comparison
Compare TRV & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRV
- HLN
- Stock Information
- Founded
- TRV 1853
- HLN 2022
- Country
- TRV United States
- HLN United Kingdom
- Employees
- TRV N/A
- HLN N/A
- Industry
- TRV Property-Casualty Insurers
- HLN Package Goods/Cosmetics
- Sector
- TRV Finance
- HLN Consumer Discretionary
- Exchange
- TRV Nasdaq
- HLN Nasdaq
- Market Cap
- TRV 60.1B
- HLN 48.2B
- IPO Year
- TRV 1996
- HLN N/A
- Fundamental
- Price
- TRV $284.57
- HLN $8.95
- Analyst Decision
- TRV Hold
- HLN Hold
- Analyst Count
- TRV 15
- HLN 1
- Target Price
- TRV $283.93
- HLN N/A
- AVG Volume (30 Days)
- TRV 1.0M
- HLN 9.0M
- Earning Date
- TRV 10-16-2025
- HLN 07-31-2025
- Dividend Yield
- TRV 1.55%
- HLN 2.03%
- EPS Growth
- TRV 43.22
- HLN 41.64
- EPS
- TRV 22.64
- HLN 0.23
- Revenue
- TRV $47,838,000,000.00
- HLN $15,096,588,575.00
- Revenue This Year
- TRV N/A
- HLN $1.13
- Revenue Next Year
- TRV $4.20
- HLN $4.23
- P/E Ratio
- TRV $12.57
- HLN $19.08
- Revenue Growth
- TRV 8.54
- HLN N/A
- 52 Week Low
- TRV $224.62
- HLN $8.71
- 52 Week High
- TRV $286.17
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- TRV 64.14
- HLN 38.01
- Support Level
- TRV $275.52
- HLN $8.71
- Resistance Level
- TRV $280.06
- HLN $9.09
- Average True Range (ATR)
- TRV 4.13
- HLN 0.11
- MACD
- TRV 0.33
- HLN -0.01
- Stochastic Oscillator
- TRV 89.68
- HLN 32.00
About TRV The Travelers Companies Inc.
Travelers offers a broad product range and participates in both commercial and personal insurance lines. Its commercial operations offer a variety of coverage types for companies of any size but concentrate on serving midsize businesses. Its personal lines are roughly evenly split between auto and homeowners insurance.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.